Transcription Factor Nrf2
The special issue entitled “Transcription Factor Nrf2“, edited by Prof. Dr. Antonio Cuadrado (Autonomous University of Madrid, Spain), is open for submission in the Antioxidants journal published by MDPI (impact factor 6.313). This issue aims to present the current knowledge about the role of NRF2 in the pathophysiology of several NCDs including cancer, diabetes, autoimmune, cardiovascular, and neurodegenerative diseases, among others, as well as in the identification of NRF2 as a novel anti-inflammatory target in infectious diseases, including Covid-19. BenBedPhar participants are invited to submit their latest research findings to this Special Issue. At this time, this special issue accounts with 9 published articles. The deadline for the submission is the 20th of June 2022.
